Searched for
ROMARK LABORATORIES
Lupin launches generic diarrhea drug in US marketNitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12...
Lupin eyes acquisitions in US, Europe to bolster overseas presenceLupin, which has already entered the Mexican market, would also continue to look for acquisitions in key Latam markets such as Brazil.
Lupin gets USFDA nod for additional strengths of cholesterol drug"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," Lupin said.